Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hansen D et al. – Hyperparathyroidism, hypercalcemia and hyperphosphatemia are associated with increased cardiovascular mortality in patients with chronic kidney disease. If there is any difference in the ability of these two vitamin D analogs to decrease the secondary hyperparathyroidism without causing hypercalcemia and hyperphosphatemia, there may also be a difference in the risk of cardiovascular mortality depending on which vitamin D analog that are used. This has potential major importance for this group of patients.

Today in Endocrinology...keeping you current

Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09

Today in Pharmacology/kinetics...keeping you current

Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrology Dialysis Transplantation, 11/25/09

Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Hypertension, 11/24/09

Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid
Clinical and Experimental Nephrology, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address